Neuronetics, Inc.

NASDAQ:STIM

Medical - Diagnostics & Research

Healthcare
$1.25 +0.31%

+$0.00 today

Market cap
$97.16M
Beta
1.04
P/E (TTM)
-2.3
EPS (TTM)
-$0.53
52W Low $0.80High $4.85

Volume 2.55M

Average 2.44M

STIM Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Neuronetics, Inc.NASDAQ: STIM

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 46.9%

Gross margin was 46.9% in Q1 FY2026, down 2.3 pp from a year earlier. On a trailing-twelve-month basis it was 48.0%, down 15.6 pp year over year. Over 3 fiscal years it narrowed by 27.8 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
46.9%-5.1 pp QoQ
Last fiscal yearDec 2025
48.5%-23.8 pp YoY
LTMMar 2026
48.0%-15.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-2.3 pp——
1 year-23.8 pp——
3 years-27.8 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
48.5%
Year-over-year change
-23.8pp

Gross Margin vs competitors

How STIM compares with its peers on the latest reported figures

  • STIM's LTM Mar 2026 gross margin of 48.0% is the 6th highest of the 10 companies compared; the peer median is 48.3%.
  • Its year-over-year change of -15.6 pp is the 7th highest of 10, against a peer median of -0.1 pp.
  • Over three fiscal years its change of -27.8 pp compares with a peer median of +0.4 pp.
STIM Competitors Peer median
Gross Margin for STIM and competitors
Company Period LTM level YoY 3-year change
SGMOSangamo Therapeutics, Inc.LTM Mar 2026100.0% +0.0 pp-8.3 pp
CDXSCodexis, Inc.LTM Mar 202683.9% +12.4 pp+14.2 pp
PROFProfound Medical Corp.LTM Mar 202671.1% +4.4 pp+25.6 pp
PREPrenetics Global LimitedLTM Mar 202658.3% +12.7 pp+25.3 pp
NYXHNyxoah S.A.LTM Mar 202648.3% -17.2 pp+0.4 pp
STIMNeuronetics, Inc.LTM Mar 202648.0% -15.6 pp-27.8 pp
OSUROraSure Technologies, Inc.LTM Mar 202641.0% -1.5 pp+3.6 pp
OABIOmniAb, Inc.LTM Mar 202635.5% -64.5 pp-118.2 pp
ATLNAtlantic International Corp.LTM Dec 202510.6% -0.1 pp-1.7 pp
CATXPerspective Therapeutics, Inc.LTM Mar 2026-489.8% -407.5 pp-290.8 pp
Peer median (excluding STIM) 48.3%-0.1 pp+0.4 pp

Competitors are the stored peer set for STIM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue55.31M65.21M71.35M74.89M149.16M
Cost of Revenue11.65M15.48M19.64M20.73M76.85M
Gross Profit43.66M49.72M51.71M54.16M72.31M
Gross Margin78.9%76.3%72.5%72.3%48.5%
Research & Development7.92M9.34M9.52M12.77M6.58M
Selling, General & Admin63.3M75.5M72.74M75.95M97.16M
Operating Expenses71.22M84.83M82.26M88.72M103.74M
Depreciation & Amortization1.06M1.65M2.01M2.07M3.47M
EBITDA(26.81M)(31.96M)(22.76M)(34.37M)(27.12M)
EBITDA Margin-48.5%-49.0%-31.9%-45.9%-18.2%
Operating Income(27.56M)(35.11M)(30.55M)(34.56M)(31.44M)
Operating Margin-49.8%-53.8%-42.8%-46.2%-21.1%
Interest Income0024K00
Interest Expense3.3M3.6M5.42M7.29M8.42M
Other Income / Expenses(3.61M)(2.1M)365K(9.18M)(7.56M)
Income Before Tax(31.17M)(37.21M)(30.19M)(43.74M)(39M)
Pre-Tax Margin-56.4%-57.1%-42.3%-58.4%-26.1%
Income Tax Expense00(24K)(14K)0
Net Income(31.19M)(37.16M)(30.19M)(43.71M)(39M)
Net Margin-56.4%-57.0%-42.3%-58.4%-26.1%
EPS (Basic)(1.22)(1.38)(1.05)(1.38)(0.59)
EPS (Diluted)(1.22)(1.38)(1.05)(1.38)(0.59)
Weighted Avg Shares25.48M26.9M28.66M31.73M65.95M
Weighted Avg Shares (Diluted)25.48M26.9M28.66M31.73M65.95M

Neuronetics, Inc.

NASDAQ:STIM

Intrinsic Alpha fair value

Locked

Current Price

$1.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.